Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the study record itself.
    Difference
    0.0%
    Check dated 2026-04-24T22:22:37.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:55:05.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Added revision tag v3.5.0 and removed revision tag v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T23:50:22.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3, reflecting a minor update to the page version. It does not affect the study content.
    Difference
    0.0%
    Check dated 2026-03-12T20:31:12.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision updates: added v3.4.2 and removed v3.4.1. These changes are minor and do not affect study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T00:34:36.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:48:29.000Z thumbnail image

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.